引用次数
引用: 674
H-指数: 15
I10-指数 : 16
出版物: 23
Identification and characterization of novel candidate compounds targeting 6- and 7-transmembrane μ-opioid receptor isoforms.
Nikolay V. Dokholyan , Nikolay V. Dokholyan , Jeffrey S. Mogil , Luda Diatchenko
British Journal of Pharmacology
2021
A Small Molecule Angiotensin II Type 2 Receptor (AT2R) Antagonist Produces Analgesia in a Rat Model of Neuropathic Pain by Inhibition of p38 Mitogen-Activated Protein Kinase (MAPK) and p44/p42 MAPK Activation in the Dorsal Root Ganglia
Maree T. Smith , Trent M. Woodruff , Bruce D. Wyse , Arjun Muralidharan
Pain Medicine 14 ( 10) 1557 -1568
50
2013
Analgesic Efficacy and Mode of Action of a Selective Small Molecule Angiotensin II Type 2 Receptor Antagonist in a Rat Model of Prostate Cancer‐Induced Bone Pain
Arjun Muralidharan , Bruce D. Wyse , Maree T. Smith
Pain Medicine 15 ( 1) 93 -110
30
2014
Comment On "protective Arms of the Renin-Angiotensin System in Neurological Disease"
Maree T Smith , Arjun Muralidharan
Clinical and Experimental Pharmacology and Physiology 40 ( 11) 838 -838
2013
Peripheral straightjacket (α2δ Ca2+ channel subunit) expression is required for neuropathic sensitization in Drosophila.
Thang M. Khuong , Zina Hamoudi , John Manion , Lipin Loo
Philosophical Transactions of the Royal Society B 374 ( 1785) 20190287
4
2019
Attenuation of the Infiltration of Angiotensin II Expressing CD3+ T-Cells and the Modulation of Nerve Growth Factor in Lumbar Dorsal Root Ganglia – A Possible Mechanism Underpinning Analgesia Produced by EMA300, An Angiotensin II Type 2 (AT2) Receptor Antagonist
Nemat Khan , Arjun Muralidharan , Maree T. Smith
Frontiers in Molecular Neuroscience 10 389
6
2017
Pain, analgesia and genetics.
Arjun Muralidharan , Maree T. Smith
Journal of Pharmacy and Pharmacology 63 ( 11) 1387 -1400
39
2011
Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments
Arjun Muralidharan , Maree T. Smith
Inflammopharmacology 21 ( 5) 339 -363
28
2013
Optimization and characterization of a rat model of prostate cancer-induced bone pain using behavioral, pharmacological, radiological, histological and immunohistochemical methods.
Arjun Muralidharan , Bruce D. Wyse , Maree T. Smith
Pharmacology, Biochemistry and Behavior 106 33 -46
20
2013
Establishment and Characterization of a Novel Rat Model of Mechanical Low Back Pain Using Behavioral, Pharmacologic and Histologic Methods
Arjun Muralidharan , Thomas SW Park , John T Mackie , Luiz GS Gimenez
Frontiers in Pharmacology 8 493
9
2017
Comparison of Burrowing and Stimuli-Evoked Pain Behaviors as End-Points in Rat Models of Inflammatory Pain and Peripheral Neuropathic Pain
Andy Kuo , Meera Jacob , Jacintha S. Lourdesamy , Lara Melo Soares Pinho De Carvalho
Frontiers in Behavioral Neuroscience 10 ( 88) 88 -88
18
2016
Pharmacogenetics of Pain
Maree T Smith , Arjun Muralidharan
eLS 1 -12
1
2013
Long-term male-specific chronic pain via telomere-and p53-mediated spinal cord cellular senescence
Arjun Muralidharan , Susana G Sotocinal , Noosha Yousefpour , Nur Akkurt
The Journal of Clinical Investigation 132 ( 8)
9
2022
The influence of aging and duration of nerve injury on the antiallodynic efficacy of analgesics in laboratory mice
Arjun Muralidharan , Susana G Sotocinal , Jean-Sebastien Austin , Jeffrey S Mogil
Pain reports 5 ( 3) e824 -e824
18
2020
Chronic pain and premature mortality in men and women, using data from UK Biobank. Reply.
Marc Parisien , Audrey V Grant , Arjun Muralidharan , Luda Diatchenko
The Journal of Clinical Investigation 133 ( 5)
2023
Pain pharmacology and the pharmacological management of pain
Maree T Smith , Arjun Muralidharan
Pain-E-Book: Pain-E-Book 225 -225
13
2022
Pharmacogenetics
MT SMITH , A MURALIDHARAN
Pain: Clinical Updates 1 -8
2010
Pharmacogenetics of pain and analgesia.
MT Smith , A Muralidharan
Clinical Genetics 82 ( 4) 321 -330
25
2012
Discover Oncology
AE Smith , A Muralidharan , MT Smith
2022
Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain
M.T. Smith , A Muralidharan
Expert Opinion on Therapeutic Targets
54
2014